Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial

Author:

Stone William,Mahamar Almahamoudou,Sanogo Koualy,Sinaba Youssouf,Niambele Sidi M,Sacko Adama,Keita Sekouba,Youssouf Ahamadou,Diallo Makonon,Soumare Harouna M,Kaur Harparkash,Lanke Kjerstin,ter Heine Rob,Bradley John,Issiaka Djibrilla,Diawara Halimatou,Traore Sekou F,Bousema Teun,Drakeley Chris,Dicko Alassane

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference30 articles.

1. Large-scale artemisinin–piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa;Deng;Clin Infect Dis,2018

2. Malaria medicines to address drug resistance and support malaria elimination efforts;Achan;Expert Rev Clin Pharmacol,2018

3. The use of artesunate–pyronaridine for the treatment of uncomplicated malaria,2019

4. Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study;Amaratunga;Lancet Infect Dis,2016

5. Artemether–lumefantrine versus dihydroartemisinin–piperaquine for treatment of malaria: a randomized trial;Kamya;PLoS Clin Trials,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3